Ran Jin

1.3k total citations
33 papers, 818 citations indexed

About

Ran Jin is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Immunology. According to data from OpenAlex, Ran Jin has authored 33 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 14 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Immunology. Recurrent topics in Ran Jin's work include Liver Disease Diagnosis and Treatment (15 papers), Biosimilars and Bioanalytical Methods (10 papers) and Diet, Metabolism, and Disease (9 papers). Ran Jin is often cited by papers focused on Liver Disease Diagnosis and Treatment (15 papers), Biosimilars and Bioanalytical Methods (10 papers) and Diet, Metabolism, and Disease (9 papers). Ran Jin collaborates with scholars based in United States, Austria and Canada. Ran Jin's co-authors include Miriam B. Vos, Dean P. Jones, Ngoc‐Anh Le, Juna V. Konomi, Jean A. Welsh, David V. Conti, Douglas I. Walker, Cheng Peng, Craig J. McClain and Puneet Sharma and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Journal of the American College of Cardiology.

In The Last Decade

Ran Jin

30 papers receiving 810 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ran Jin United States 14 398 306 230 191 171 33 818
Akiko Uno Japan 10 316 0.8× 117 0.4× 407 1.8× 43 0.2× 432 2.5× 21 1.0k
Aidan McGlinchey Finland 11 118 0.3× 47 0.2× 195 0.8× 73 0.4× 154 0.9× 15 684
Jian Jin China 18 173 0.4× 104 0.3× 33 0.1× 115 0.6× 114 0.7× 49 862
Kyungeun Song South Korea 10 89 0.2× 69 0.2× 36 0.2× 91 0.5× 434 2.5× 15 908
Ville Männistö Finland 26 1.3k 3.2× 635 2.1× 30 0.1× 403 2.1× 58 0.3× 60 2.0k
Hyoung Woo Lee South Korea 18 149 0.4× 360 1.2× 16 0.1× 128 0.7× 76 0.4× 55 907
Reginald G. Hanson United States 10 1.4k 3.5× 533 1.7× 754 3.3× 115 0.6× 633 3.7× 13 2.4k
Mikio Doy Japan 16 144 0.4× 45 0.1× 42 0.2× 72 0.4× 32 0.2× 37 742
Binghai Zhao China 17 50 0.1× 123 0.4× 217 0.9× 24 0.1× 309 1.8× 30 871

Countries citing papers authored by Ran Jin

Since Specialization
Citations

This map shows the geographic impact of Ran Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Jin more than expected).

Fields of papers citing papers by Ran Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ran Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Jin. The network helps show where Ran Jin may publish in the future.

Co-authorship network of co-authors of Ran Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Ran Jin. A scholar is included among the top collaborators of Ran Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ran Jin. Ran Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jin, Ran, et al.. (2023). Real-World Experience of Adalimumab Biosimilar (ABP 501) Use in Patients with Inflammatory Bowel Disease in Europe. Advances in Therapy. 41(1). 331–348. 6 indexed citations
2.
Jin, Ran, et al.. (2022). REAL-WORLD UTILIZATION OF ADALIMUMAB BIOSIMILAR (ABP 501) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN EUROPE. Gastroenterology. 162(3). S109–S110. 1 indexed citations
3.
Jin, Ran, et al.. (2022). REAL-WORLD UTILIZATION OF ADALIMUMAB BIOSIMILAR (ABP 501) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN EUROPE. Inflammatory Bowel Diseases. 28(Supplement_1). S109–S110.
4.
Accortt, Neil A., et al.. (2021). Real-world use of bevacizumab-awwb, a bevacizumab biosimilar, in US patients with metastatic colorectal cancer. Future Oncology. 17(36). 5119–5127. 10 indexed citations
5.
Accortt, Neil A., et al.. (2021). Demographics and clinical characteristics of metastatic colorectal cancer patients treated with bevacizumab-awwb in real-world oncology clinics.. Journal of Clinical Oncology. 39(3_suppl). 90–90. 1 indexed citations
6.
Jin, Ran, et al.. (2021). Initial experience of patients treated in a real-world clinical setting with bevacizumab-awwb: The first FDA-approved biosimilar to bevacizumab.. Journal of Clinical Oncology. 39(3_suppl). 81–81. 1 indexed citations
7.
Alderete, Tanya L., Ran Jin, Douglas I. Walker, et al.. (2019). Perfluoroalkyl substances, metabolomic profiling, and alterations in glucose homeostasis among overweight and obese Hispanic children: A proof-of-concept analysis. Environment International. 126. 445–453. 128 indexed citations
8.
Jin, Ran, Rob McConnell, Catherine E. Cioffi, et al.. (2019). Perfluoroalkyl substances and severity of nonalcoholic fatty liver in Children: An untargeted metabolomics approach. Environment International. 134. 105220–105220. 151 indexed citations
9.
Vos, Miriam B., Ran Jin, Juna V. Konomi, et al.. (2018). A randomized, controlled, crossover pilot study of losartan for pediatric nonalcoholic fatty liver disease. Pilot and Feasibility Studies. 4(1). 109–109. 19 indexed citations
10.
Frediani, Jennifer K., Wen Chen, Turgay Ayer, et al.. (2018). Alanine Aminotransferase as a Monitoring Biomarker in Children with Nonalcoholic Fatty Liver Disease: A Secondary Analysis Using TONIC Trial Data. Children. 5(6). 64–64. 26 indexed citations
11.
He, Siran, Ngoc‐Anh Le, Jennifer K. Frediani, et al.. (2017). Cardiometabolic risks vary by weight status in pediatric kidney and liver transplant recipients: A cross‐sectional, single‐center study in the USA. Pediatric Transplantation. 21(6). 5 indexed citations
12.
Jin, Ran, Sophia Banton, ViLinh Tran, et al.. (2016). Amino Acid Metabolism is Altered in Adolescents with Nonalcoholic Fatty Liver Disease—An Untargeted, High Resolution Metabolomics Study. The Journal of Pediatrics. 172. 14–19.e5. 79 indexed citations
13.
Vos, Miriam B., Ran Jin, Jean A. Welsh, et al.. (2016). 500 Losartan Improves Hepatic Inflammation in Children With Non-Alcoholic Fatty Liver Disease. Gastroenterology. 150(4). S1036–S1036. 4 indexed citations
14.
Jin, Ran & Miriam B. Vos. (2015). Fructose and liver function – is this behind nonalcoholic liver disease?. Current Opinion in Clinical Nutrition & Metabolic Care. 18(5). 490–495. 19 indexed citations
15.
Jin, Ran, Ngoc‐Anh Le, Rebecca Cleeton, et al.. (2015). Amount of hepatic fat predicts cardiovascular risk independent of insulin resistance among Hispanic-American adolescents. Lipids in Health and Disease. 14(1). 39–39. 30 indexed citations
16.
Jin, Ran, Ngoc‐Anh Le, Thomas R. Ziegler, et al.. (2015). Plasminogen Activator Inhibitor‐1 Predicts Quantity of Hepatic Steatosis Independent of Insulin Resistance and Body Weight. Journal of Pediatric Gastroenterology and Nutrition. 62(6). 819–823. 13 indexed citations
17.
Jin, Ran, Shivani Patel, Xiaoyan Sun, et al.. (2014). Fructose Induced Endotoxemia in Pediatric Nonalcoholic Fatty Liver Disease. International Journal of Hepatology. 2014. 1–8. 84 indexed citations
18.
Lê, Anh, Ran Jin, Andrew M. Tershakovec, et al.. (2012). CHANGES IN LIPOPROTEIN PARTICLE NUMBER WITH EZETIMIBE/SIMVASTATIN COADMINISTERED WITH EXTENDED-RELEASE NIACIN IN PATIENTS WITH TYPE II HYPERLIPIDEMIA. Journal of the American College of Cardiology. 59(13). E1691–E1691. 1 indexed citations
19.
Jin, Ran, Ngoc‐Anh Le, Shilin Liu, et al.. (2012). Children with NAFLD Are More Sensitive to the Adverse Metabolic Effects of Fructose Beverages than Children without NAFLD. The Journal of Clinical Endocrinology & Metabolism. 97(7). E1088–E1098. 67 indexed citations
20.
Le, Ngoc‐Anh, Ran Jin, Andrew M. Tershakovec, et al.. (2012). Changes in Lipoprotein-associated Phospholipase A2 with Ezetimibe/Simvastatin Co-administered with ER Niacin in Type II Hyperlipidemia. Journal of clinical lipidology. 6(3). 253–254. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Akiko Uno Breakdown of academic impact, for papers by Aidan McGlinchey Breakdown of academic impact, for papers by Jian Jin Breakdown of academic impact, for papers by Kyungeun Song Breakdown of academic impact, for papers by Ville Männistö Breakdown of academic impact, for papers by Hyoung Woo Lee Breakdown of academic impact, for papers by Reginald G. Hanson Breakdown of academic impact, for papers by Mikio Doy Breakdown of academic impact, for papers by Binghai Zhao
Rankless by CCL
2026